The GLIOMATCH project has officially started in January 2024

Under the coordination of KU Leuven, the multidisciplinary consortium will be working on pioneering personalised therapies for brain cancer patients.

Under the coordination of KU Leuven, the multidisciplinary consortium will be working on pioneering personalised therapies for brain cancer patients.